Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$41.14 Mil
% of Total Estimate Gain
14.78%

T. Rowe Price U.S. Large-Cap Core Fund, Inc.'s AbbVie Inc Holding Summary

As of 2025-03-31, T. Rowe Price U.S. Large-Cap Core Fund, Inc. held - shares of AbbVie Inc(ABBV), totaling N/A. This investment constitutes 0% of their stock portfolio, and T. Rowe Price U.S. Large-Cap Core Fund, Inc. now holds 0% of the outstanding AbbVie Inc(ABBV) stock.

The initial trade took place in 2019Q3. And since then T. Rowe Price U.S. Large-Cap Core Fund, Inc. has made 8 purchases of ABBV, at an average price of $151.26, for a total of 1.84 Mil shares. In addition, there have been 5 sales at an average price of $173.62 for 1.84 Mil shares. Based on historical transaction data and ABBV's current price of $187.63, T. Rowe Price U.S. Large-Cap Core Fund, Inc.'s estimated gain on his ABBV holdings is $41.14 Mil, reflecting a 14.78% gain to date.

T. Rowe Price U.S. Large-Cap Core Fund, Inc. ABBV ($187.63) Holding Chart

T. Rowe Price U.S. Large-Cap Core Fund, Inc. ABBV ($187.63) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1